2023-05-25 |
13D |
BCDA / BioCardia, Inc. |
Daly Joseph Patrick |
758,540 |
3.75 |
0.00 |
2023-05-23 |
13D/A |
IBRX / ImmunityBio, Inc. |
Cambridge Equities, LP |
384,747,663 |
77.30 |
4.05 |
2023-05-19 |
13D/A |
ACLX / Arcellx, Inc. |
Sr One Capital Management, Llc |
4,487,174 |
9.35 |
-18.42 |
2023-05-18 |
13D/A |
ABCZF / Abcam Limited |
Milner Jonathan |
14,428,202 |
6.28 |
|
2023-05-17 |
13D/A |
WINT / Windtree Therapeutics, Inc. |
Huang James |
75,609 |
1.50 |
|
2023-05-16 |
13D/A |
MGTX / MeiraGTx Holdings plc |
Perceptive Advisors Llc |
11,406,563 |
19.10 |
63.56 |
2023-05-12 |
13D/A |
PMCB / PharmaCyte Biotech, Inc. |
Iroquois Capital Management, LLC |
1,242,615 |
7.00 |
-10.59 |
2023-05-08 |
13D/A |
PHGE / BiomX Inc. |
OrbiMed Israel BioFund GP Limited Partnership |
4,553,489 |
9.90 |
28.76 |
2023-05-05 |
13D/A |
HLVX / HilleVax, Inc. |
Frazier Life Sciences Public Fund, L.P. |
9,781,472 |
25.00 |
1.50 |
2023-05-03 |
13D/A |
INKT / MiNK Therapeutics, Inc. |
Agenus Inc |
21,344,685 |
62.00 |
|
2023-05-01 |
13D |
ABCZF / Abcam Limited |
Milner Jonathan |
14,685,202 |
6.40 |
0.00 |
2023-04-27 |
13D |
NVAX / Novavax, Inc. |
Shah Capital Management |
4,550,756 |
5.28 |
|
2023-04-20 |
13D/A |
REPCF / 0913693 B.C. Ltd. |
Schutte Andrew |
25,104,422 |
34.53 |
34.80 |
2023-04-19 |
13D/A |
FATE / Fate Therapeutics, Inc. |
Redmile Group, LLC |
15,071,096 |
14.90 |
15.99 |
2023-04-19 |
13D/A |
WINT / Windtree Therapeutics, Inc. |
Huang James |
|
|
|
2023-04-19 |
13D/A |
TBIO / Telesis Bio, Inc. |
Northpond Ventures, LP |
9,844,130 |
33.20 |
0.00 |
2023-04-18 |
13D/A |
CASI / CASI Pharmaceuticals, Inc. |
He Wei-Wu |
2,837,891 |
19.75 |
|
2023-04-07 |
13D/A |
EXEL / Exelixis, Inc. |
Farallon Capital Partners, L.P. |
23,466,000 |
7.20 |
0.00 |
2023-03-31 |
13D |
ZURA / Zura Bio Limited |
Athanor Capital, Lp |
6,801,633 |
25.14 |
|
2023-03-30 |
13D/A |
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) |
New Enterprise Associates 14, L.P. |
102,478,672 |
10.30 |
3.60 |
2023-03-28 |
13D/A |
ZURA / Zura Bio Limited |
JATT Ventures, L.P. |
5,081,534 |
17.30 |
|
2023-03-27 |
13D/A |
EXEL / Exelixis, Inc. |
Farallon Capital Partners, L.P. |
23,466,000 |
7.20 |
0.00 |
2023-03-27 |
13D/A |
EXEL / Exelixis, Inc. |
Caligan Partners LP |
850,000 |
0.26 |
0.00 |
2023-03-20 |
13D |
EXEL / Exelixis, Inc. |
Caligan Partners LP |
850,000 |
0.26 |
|
2023-03-20 |
13D |
EXEL / Exelixis, Inc. |
Farallon Capital Partners, L.P. |
23,466,000 |
7.20 |
|
2023-03-17 |
13D/A |
PHGE / BiomX Inc. |
OrbiMed Israel BioFund GP Limited Partnership |
3,536,489 |
10.50 |
|
2023-03-03 |
13D/A |
SCLX / Scilex Holding Company |
Sorrento Therapeutics, Inc. |
95,533,509 |
44.20 |
0.00 |
2023-02-24 |
13D |
IKT / Inhibikase Therapeutics, Inc. |
FiveT Investment Management Ltd |
1,341,000 |
4.78 |
-11.60 |
2023-02-24 |
13D/A |
VYGR / Voyager Therapeutics, Inc. |
Neurocrine Biosciences Inc |
8,575,316 |
19.90 |
105.16 |
2023-02-23 |
13D/A |
WINT / Windtree Therapeutics, Inc. |
Huang James |
3,780,442 |
8.70 |
0.00 |
2023-02-21 |
13D/A |
TNYA / Tenaya Therapeutics, Inc. |
Column Group Iii, Lp |
11,370,274 |
17.80 |
18.25 |
2023-02-21 |
13D/A |
CASI / CASI Pharmaceuticals, Inc. |
Ho Chi Sing |
1,053,638 |
7.70 |
-89.30 |
2023-02-14 |
13D |
SRRK / Scholar Rock Holding Corporation |
Samsara BioCapital, L.P. |
5,676,076 |
10.80 |
|
2023-02-14 |
13D/A |
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) |
Bpifrance Participations SA |
6,427,497 |
11.60 |
62.25 |
2023-02-14 |
13D/A |
ZIVO / ZIVO Bioscience, Inc. |
Maggiore Christopher D. |
979,744 |
10.20 |
-98.29 |
2023-02-13 |
13D/A |
SRZN / Surrozen, Inc. |
Column Group Iii Gp, Lp |
9,414,795 |
31.50 |
0.00 |
2023-02-09 |
13D/A |
WINT / Windtree Therapeutics, Inc. |
Huang James |
3,780,442 |
8.60 |
|
2023-02-03 |
13D/A |
SLDB / Solid Biosciences Inc. |
Perceptive Advisors Llc |
3,501,265 |
17.90 |
0.00 |
2023-01-31 |
13D |
IKT / Inhibikase Therapeutics, Inc. |
FiveT Investment Management Ltd |
1,517,000 |
4.12 |
0.00 |
2023-01-26 |
13D/A |
REPCF / 0913693 B.C. Ltd. |
Schutte Andrew |
18,624,006 |
31.17 |
123.00 |
2023-01-26 |
13D/A |
CRDF / Cardiff Oncology, Inc. |
Acorn Bioventures, L.p. |
3,043,173 |
6.38 |
-49.20 |
2023-01-24 |
13D/A |
ACLX / Arcellx, Inc. |
New Enterprise Associates 15, L.P. |
4,746,494 |
10.80 |
-26.21 |
2023-01-23 |
13D/A |
SCLX / Scilex Holding Company |
Sorrento Therapeutics, Inc. |
95,533,509 |
45.50 |
-43.10 |
2023-01-17 |
13D/A |
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) |
General Atlantic Llc |
3,225,700 |
7.10 |
-16.01 |
2023-01-13 |
13D/A |
IOVA / Iovance Biotherapeutics, Inc. |
Quogue Capital LLC |
20,000,000 |
12.52 |
122.22 |
2023-01-10 |
13D/A |
ARMP / Armata Pharmaceuticals, Inc. |
Innoviva, Inc. |
64,178,259 |
85.30 |
44.41 |
2023-01-09 |
13D/A |
BCAB / BioAtla, Inc. |
Soleus Private Equity Fund I, L.P. |
4,220,397 |
9.20 |
87.78 |
2023-01-09 |
13D/A |
BCDA / BioCardia, Inc. |
Stertzer Simon H |
1,909,185 |
9.30 |
-78.01 |
2023-01-09 |
13D/A |
BCDA / BioCardia, Inc. |
Allen Jim L. |
1,341,782 |
6.50 |
32.00 |
2023-01-05 |
13D/A |
REPCF / 0913693 B.C. Ltd. |
Mackay Jamie Myles |
8,864,037 |
16.41 |
29.61 |